[SCHEDULE 13G/A] Imunon, Inc. SEC Filing
Imunon, Inc. received a Schedule 13G/A reporting that three related reporting persons 鈥� Ayrton Capital LLC, Alto Opportunity Master Fund, SPC (Segregated Master Portfolio B) and individual Waqas Khatri 鈥� each beneficially own 2,000 shares of the issuer's common stock that are issuable on the exercise of certain warrants and conversion of certain convertible notes. The filing states these holdings represent 0.01% each based on 17,541,732 shares outstanding cited in the issuer's registration statement prior to a July 2025 reverse stock split.
The filing notes the warrants are subject to a 9.99% beneficial ownership blocker and includes a certification that the securities were acquired and are held in the ordinary course of business and not for the purpose of changing or influencing control.
Imunon, Inc. ha ricevuto un Schedule 13G/A che segnala che tre soggetti collegati 鈥� Ayrton Capital LLC, Alto Opportunity Master Fund, SPC (Segregated Master Portfolio B) e il singolo Waqas Khatri 鈥� possiedono ciascuno beneficiariamente 2.000 azioni del capitale sociale della emittente, emettibili mediante l'esercizio di determinate warrant e la conversione di determinate note convertibili. Il deposito indica che queste partecipazioni rappresentano ciascuna il 0,01% sulla base di 17.541.732 azioni in circolazione riportate nella dichiarazione di registrazione dell'emittente prima di uno split inverso azionario previsto per luglio 2025.
Il deposito precisa che le warrant sono soggette a un limite di propriet脿 beneficiaria del 9,99% e include una certificazione che i titoli sono stati acquisiti e sono detenuti nell'ordinaria attivit脿 aziendale e non per lo scopo di modificare o influenzare il controllo.
Imunon, Inc. recibi贸 un Schedule 13G/A que informa que tres personas relacionadas 鈥� Ayrton Capital LLC, Alto Opportunity Master Fund, SPC (Segregated Master Portfolio B) y el individuo Waqas Khatri 鈥� poseen beneficiariamente, cada una, 2.000 acciones del capital social de la emisora que pueden emitirse mediante el ejercicio de ciertos warrants y la conversi贸n de determinadas notas convertibles. La presentaci贸n indica que estas participaciones representan, cada una, el 0,01% sobre la base de 17.541.732 acciones en circulaci贸n citadas en la declaraci贸n de registro de la emisora antes de una consolidaci贸n inversa de acciones en julio de 2025.
La presentaci贸n se帽ala que los warrants est谩n sujetos a un bloqueador de propiedad beneficiaria del 9,99% e incluye una certificaci贸n de que los valores se adquirieron y se mantienen en el curso ordinario del negocio y no con el prop贸sito de cambiar o influir en el control.
Imunon, Inc.電� Schedule 13G/A 靹滊毳� 鞝戩垬頄堨溂氅�, 鞚� 氍胳劀鞐� 霐半ゴ氅� 甏�霠悳 靹� 氤搓碃鞛愨�擜yrton Capital LLC, Alto Opportunity Master Fund, SPC (Segregated Master Portfolio B) 氚� 臧滌澑 Waqas Khatri鈥旉皜 臧侁皝 氚滍枆須岇偓鞚� 氤错喌欤� 2,000欤�毳� 鞙犿毃頃橁矊 氤挫湢頃橁碃 鞛堧姅雿�, 鞚措姅 韸轨爼 鞗岆煱韸胳潣 頄夓偓鞕� 鞚茧秬 鞝勴櫂靷眲鞚� 鞝勴櫂鞚� 韱淀暣 氚滍枆霅� 靾� 鞛堧姅 欤检嫕鞛呺媹雼�. 鞝滌稖靹滊電� 鞚措煬頃� 氤挫湢臧� 2025雲� 7鞗� 鞐秳頃� 鞚挫爠鞐� 氚滍枆鞚胳澊 鞝滌稖頃� 霌彪氇呾劯靹滌棎 旮办灛霅� 鞙犿喌欤检嫕靾� 17,541,732欤�毳� 旮办鞙茧 臧侁皝 0.01%鞐� 頃措嫻頃滊嫟瓿� 氚濏瀳瓿� 鞛堨姷雼堧嫟.
靹滊電� 鞗岆煱韸戈皜 9.99%鞚� 歆�攵勲炒鞙� 彀嫧 臁绊暛鞚� 鞝侅毄鞚� 氚涬姅雼り碃 氇呾嫓頃橂┌, 頃措嫻 歃濌秾鞚� 韱奠儊鞝侅澑 鞓侅梾瓿检爼鞐愳劀 旆摑霅橃柎 氤挫湢霅橁碃 鞛堨溂氅� 歆�氚瓣秾鞚� 氤�瓴巾晿瓯半倶 鞓來枼霠レ潉 頄夓偓頃� 氇╈爜鞙茧 旆摑霅� 瓴冹澊 鞎勲嫎鞚� 鞚胳頃橂姅 雮挫毄霃� 韽暔頃橁碃 鞛堨姷雼堧嫟.
Imunon, Inc. a d茅pos茅 un Schedule 13G/A indiquant que trois personnes apparent茅es 鈥� Ayrton Capital LLC, Alto Opportunity Master Fund, SPC (Segregated Master Portfolio B) et l'individu Waqas Khatri 鈥� d茅tiennent chacune 脿 titre b茅n茅ficiaire 2 000 actions de l'actionnariat de l'茅metteur susceptibles d'锚tre 茅mises lors de l'exercice de certains warrants et de la conversion de certaines obligations convertibles. Le d茅p么t pr茅cise que ces participations repr茅sentent chacune 0,01 % sur la base de 17 541 732 actions en circulation cit茅es dans le document d'enregistrement de l'茅metteur avant une division invers茅e des actions pr茅vue en juillet 2025.
Le d茅p么t indique que les warrants sont soumis 脿 un plafond de d茅tention b茅n茅ficiaire de 9,99 % et comprend une certification selon laquelle les titres ont 茅t茅 acquis et sont d茅tenus dans le cours normal des affaires et non dans le but de modifier ou d'influencer le contr么le.
Imunon, Inc. hat eine Schedule 13G/A eingereicht, in der berichtet wird, dass drei verbundene Meldepflichtige 鈥� Ayrton Capital LLC, Alto Opportunity Master Fund, SPC (Segregated Master Portfolio B) und die Person Waqas Khatri 鈥� jeweils wirtschaftlich beg眉nstigt 2.000 Aktien des Stammkapitals der Emittentin besitzen, die durch die Aus眉bung bestimmter Warrants und die Umwandlung bestimmter Wandelanleihen ausgegeben werden k枚nnen. Die Einreichung gibt an, dass diese Beteiligungen jeweils 0,01% darstellen, basierend auf 17.541.732 ausstehenden Aktien, die in der Registrierungsunterlage der Emittentin vor einer Reverse-Stock-Split im Juli 2025 aufgef眉hrt sind.
In der Einreichung wird ferner darauf hingewiesen, dass die Warrants einem 9,99%-Begrenzungsmechanismus f眉r wirtschaftliches Eigentum unterliegen, und es ist eine Best盲tigung enthalten, dass die Wertpapiere im normalen Gesch盲ftsverlauf erworben und gehalten wurden und nicht zum Zweck des Wechsels oder der Beeinflussung der Kontrolle.
- Clear, specific disclosure of the number of issuable shares (2,000) and the pre-split outstanding share base (17,541,732)
- Certification that the securities are held in the ordinary course and not to change or influence control
- Beneficial ownership blocker (9.99%) limits near-term accumulation risk from the warrants
- None.
Insights
TL;DR: Small, non-control positions; limited market impact; potential dilution exists but immaterial at reported scale.
The three reporting persons each hold rights to 2,000 shares, equivalent to 0.01% of the cited 17,541,732 outstanding shares (pre-reverse-split basis). These are issuable on exercise/conversion of warrants and notes, so they represent potential dilution rather than current voting stock. The presence of a 9.99% beneficial ownership blocker limits immediate accumulation risk. Overall, at this scale the holdings are immaterial to market capitalization or governance and are unlikely to move pricing or influence strategic decisions.
TL;DR: Filing shows compliance and clarifies no intent to influence control; governance risk is minimal.
The disclosure identifies the investment manager, fund vehicle and the individual managing member as reporting persons and states the securities are held in the ordinary course of business with no intent to affect control. The filing documents sole voting and dispositive power over the reported 2,000 issuable shares for each filer and notes the 9.99% ownership blocker on the warrant-related shares. From a governance perspective this is a routine transparency filing with no apparent control implications.
Imunon, Inc. ha ricevuto un Schedule 13G/A che segnala che tre soggetti collegati 鈥� Ayrton Capital LLC, Alto Opportunity Master Fund, SPC (Segregated Master Portfolio B) e il singolo Waqas Khatri 鈥� possiedono ciascuno beneficiariamente 2.000 azioni del capitale sociale della emittente, emettibili mediante l'esercizio di determinate warrant e la conversione di determinate note convertibili. Il deposito indica che queste partecipazioni rappresentano ciascuna il 0,01% sulla base di 17.541.732 azioni in circolazione riportate nella dichiarazione di registrazione dell'emittente prima di uno split inverso azionario previsto per luglio 2025.
Il deposito precisa che le warrant sono soggette a un limite di propriet脿 beneficiaria del 9,99% e include una certificazione che i titoli sono stati acquisiti e sono detenuti nell'ordinaria attivit脿 aziendale e non per lo scopo di modificare o influenzare il controllo.
Imunon, Inc. recibi贸 un Schedule 13G/A que informa que tres personas relacionadas 鈥� Ayrton Capital LLC, Alto Opportunity Master Fund, SPC (Segregated Master Portfolio B) y el individuo Waqas Khatri 鈥� poseen beneficiariamente, cada una, 2.000 acciones del capital social de la emisora que pueden emitirse mediante el ejercicio de ciertos warrants y la conversi贸n de determinadas notas convertibles. La presentaci贸n indica que estas participaciones representan, cada una, el 0,01% sobre la base de 17.541.732 acciones en circulaci贸n citadas en la declaraci贸n de registro de la emisora antes de una consolidaci贸n inversa de acciones en julio de 2025.
La presentaci贸n se帽ala que los warrants est谩n sujetos a un bloqueador de propiedad beneficiaria del 9,99% e incluye una certificaci贸n de que los valores se adquirieron y se mantienen en el curso ordinario del negocio y no con el prop贸sito de cambiar o influir en el control.
Imunon, Inc.電� Schedule 13G/A 靹滊毳� 鞝戩垬頄堨溂氅�, 鞚� 氍胳劀鞐� 霐半ゴ氅� 甏�霠悳 靹� 氤搓碃鞛愨�擜yrton Capital LLC, Alto Opportunity Master Fund, SPC (Segregated Master Portfolio B) 氚� 臧滌澑 Waqas Khatri鈥旉皜 臧侁皝 氚滍枆須岇偓鞚� 氤错喌欤� 2,000欤�毳� 鞙犿毃頃橁矊 氤挫湢頃橁碃 鞛堧姅雿�, 鞚措姅 韸轨爼 鞗岆煱韸胳潣 頄夓偓鞕� 鞚茧秬 鞝勴櫂靷眲鞚� 鞝勴櫂鞚� 韱淀暣 氚滍枆霅� 靾� 鞛堧姅 欤检嫕鞛呺媹雼�. 鞝滌稖靹滊電� 鞚措煬頃� 氤挫湢臧� 2025雲� 7鞗� 鞐秳頃� 鞚挫爠鞐� 氚滍枆鞚胳澊 鞝滌稖頃� 霌彪氇呾劯靹滌棎 旮办灛霅� 鞙犿喌欤检嫕靾� 17,541,732欤�毳� 旮办鞙茧 臧侁皝 0.01%鞐� 頃措嫻頃滊嫟瓿� 氚濏瀳瓿� 鞛堨姷雼堧嫟.
靹滊電� 鞗岆煱韸戈皜 9.99%鞚� 歆�攵勲炒鞙� 彀嫧 臁绊暛鞚� 鞝侅毄鞚� 氚涬姅雼り碃 氇呾嫓頃橂┌, 頃措嫻 歃濌秾鞚� 韱奠儊鞝侅澑 鞓侅梾瓿检爼鞐愳劀 旆摑霅橃柎 氤挫湢霅橁碃 鞛堨溂氅� 歆�氚瓣秾鞚� 氤�瓴巾晿瓯半倶 鞓來枼霠レ潉 頄夓偓頃� 氇╈爜鞙茧 旆摑霅� 瓴冹澊 鞎勲嫎鞚� 鞚胳頃橂姅 雮挫毄霃� 韽暔頃橁碃 鞛堨姷雼堧嫟.
Imunon, Inc. a d茅pos茅 un Schedule 13G/A indiquant que trois personnes apparent茅es 鈥� Ayrton Capital LLC, Alto Opportunity Master Fund, SPC (Segregated Master Portfolio B) et l'individu Waqas Khatri 鈥� d茅tiennent chacune 脿 titre b茅n茅ficiaire 2 000 actions de l'actionnariat de l'茅metteur susceptibles d'锚tre 茅mises lors de l'exercice de certains warrants et de la conversion de certaines obligations convertibles. Le d茅p么t pr茅cise que ces participations repr茅sentent chacune 0,01 % sur la base de 17 541 732 actions en circulation cit茅es dans le document d'enregistrement de l'茅metteur avant une division invers茅e des actions pr茅vue en juillet 2025.
Le d茅p么t indique que les warrants sont soumis 脿 un plafond de d茅tention b茅n茅ficiaire de 9,99 % et comprend une certification selon laquelle les titres ont 茅t茅 acquis et sont d茅tenus dans le cours normal des affaires et non dans le but de modifier ou d'influencer le contr么le.
Imunon, Inc. hat eine Schedule 13G/A eingereicht, in der berichtet wird, dass drei verbundene Meldepflichtige 鈥� Ayrton Capital LLC, Alto Opportunity Master Fund, SPC (Segregated Master Portfolio B) und die Person Waqas Khatri 鈥� jeweils wirtschaftlich beg眉nstigt 2.000 Aktien des Stammkapitals der Emittentin besitzen, die durch die Aus眉bung bestimmter Warrants und die Umwandlung bestimmter Wandelanleihen ausgegeben werden k枚nnen. Die Einreichung gibt an, dass diese Beteiligungen jeweils 0,01% darstellen, basierend auf 17.541.732 ausstehenden Aktien, die in der Registrierungsunterlage der Emittentin vor einer Reverse-Stock-Split im Juli 2025 aufgef眉hrt sind.
In der Einreichung wird ferner darauf hingewiesen, dass die Warrants einem 9,99%-Begrenzungsmechanismus f眉r wirtschaftliches Eigentum unterliegen, und es ist eine Best盲tigung enthalten, dass die Wertpapiere im normalen Gesch盲ftsverlauf erworben und gehalten wurden und nicht zum Zweck des Wechsels oder der Beeinflussung der Kontrolle.
FAQ
How many IMNN shares do the reporting persons beneficially own?
What percentage of IMNN does 2,000 shares represent?
Are the reported IMNN shares currently outstanding or issuable?
Is there any ownership limit or blocker on the reported shares?
Did the filers state intent to influence control of Imunon (IMNN)?
